Watching Stock Heading Into March: IBM's Turnaround in Focus
March is on the horizon, and I’m paying close attention to IBM as it heads into a new earnings cycle. The century-old...
Decide on the best retirement account to open in your 30s. Set yourself up for a successful financial future.
24,559 articlesMarch is on the horizon, and I’m paying close attention to IBM as it heads into a new earnings cycle. The century-old...
A stock that surged 49% in 2025 can still be tempting in 2026. This guide breaks down how to assess a semiconductor p...
Oil jumps amid Middle East tensions, yet midstream dividends from EPD and its peers remain steady. The sector’s fee-b...
As AI investments surge, can a lagging AI stock reverse course in 2026? This guide breaks down the signals, risks, an...
A seasoned trader argues a simple, math-driven framework could signal Bitcoin’s next bottom. The approach relies on l...
Biotech investors woke up to a sharp move in this crispr therapeutics stock after CRISPR Therapeutics announced new d...
When mining stocks fall, investors want to know the why and what next. This guide breaks down the drivers behind hecl...
HeartBeam heads into 2025 earnings with a mix of potential breakthroughs and headwinds. This guide explains what the ...
Geopolitics rattle markets, and a potential Iran conflict is no exception. This guide breaks down how stocks, oil, an...
When a growth stock down nearly 50% from its high looks tempting, it helps to separate hype from fundamentals. This g...
A biotech stock surged 75% last quarter and drew a new $9 million investment, signaling confidence from sophisticated...
Oracle is pursuing aggressive growth through heavy spending. This article breaks down the rationale, the risks, and w...